Curex
PrivateLast Round
Series A
Jul 15, 2024
Total Funding Raised
$1M
Company Overview
Curex is a telehealth company that provides a platform for at-home allergy testing, online consultations, and personalized sublingual immunotherapy.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Precision Medicine, Subscription Commerce, D2C Brands, Patient Engagement
Business Model
B2C
Customer Profile
Subscription SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Curex Comps
Public and private peers based on sector, stage, and business model.
Curex Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 15, 2024 | ||||
| Seed | Jan 28, 2021 |
Key People
Founding team and executive leadership
Curex Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Plug and Play Tech Center | Seed |
| Valedor Partners | Seed |
| Red & Blue Ventures | Seed, Series A |
| City Light Capital | Seed |
| Label Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 15, 2024
Completed a Series A funding round.
- Aug 8, 2023
Grew 67% QoQ, from 36 to 60 employees.
Curex Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Curex's valuation, stock price, and market status.
